CDK4/6 inhibitors: taking the place of chemotherapy?
Lancet Oncol
.
2019 Oct;20(10):1329-1330.
doi: 10.1016/S1470-2045(19)30507-8.
Epub 2019 Sep 4.
Authors
Azadeh Nasrazadani
1
,
Adam M Brufsky
2
Affiliations
1
University of Pittsburgh, Magee-Women's Hospital, Pittsburgh, PA, 15213, USA.
2
University of Pittsburgh, Magee-Women's Hospital, Pittsburgh, PA, 15213, USA. Electronic address: brufskyam@upmc.edu.
PMID:
31494036
DOI:
10.1016/S1470-2045(19)30507-8
No abstract available
Publication types
Comment
MeSH terms
Breast Neoplasms*
Cyclin-Dependent Kinase 4
Cyclin-Dependent Kinase 6
Female
Humans
Network Meta-Analysis
Postmenopause
Substances
CDK4 protein, human
Cyclin-Dependent Kinase 4
Cyclin-Dependent Kinase 6